Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic islets under attack: cellular and molecular effectors.

Michal Pearl-Yafe1, Ayelet Kaminitz, Esma S Yolcu

  • 1Center for Stem Cell Research, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Current Pharmaceutical Design
|March 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.

bioRxiv : the preprint server for biology·2026
Same author

Islets co-engineered with thrombomodulin and CD47 achieve sustained survival in allogeneic recipients without chronic immunosuppression.

JCI insight·2026
Same author

Elucidating the Mechanisms of SA-4-1BBL-Mediated Cancer Immunoprevention Through Advanced Informatics Approaches.

Biomolecules·2026
Same author

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.

Frontiers in oncology·2026
Same author

Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT).

Bone marrow transplantation·2026
Same author

A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis.

Genes·2025
Same journal

Precision Nanotechnology in Oral Oncology: From Biomarker-Guided Targeting to AI-Driven Theranostics.

Current pharmaceutical design·2026
Same journal

Pharmacological Insights into Medicinal Plants and Phytomolecules for the Management of Alopecia with Mechanistic Perspectives and Therapeutic Potential.

Current pharmaceutical design·2026
Same journal

Addressing Challenges, Regulatory Shifts, and the Need for Cost-Effective Alternatives for Complex Topical Formulations.

Current pharmaceutical design·2026
Same journal

The Mechanism of Huaiqihuang in the Treatment of Nephrotic Syndrome: An Integrated Study Based on Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation.

Current pharmaceutical design·2026
Same journal

Resveratrol and the NLRP3 Inflammasome: Unlocking the Anti-inflammatory Potential of a Natural Compound.

Current pharmaceutical design·2026
Same journal

The Use of Hemostatic Agents in Traumatic Bleeding: One Size Does Not Fit All.

Current pharmaceutical design·2026
See all related articles

Multiple pathways cause beta cell death in autoimmune diabetes, with perforin/granzyme and Fas/Fas-ligand (FasL) playing key roles. Understanding these mechanisms is crucial for developing effective diabetes treatments.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Beta cell apoptosis is implicated in autoimmune diabetes, but underlying mechanisms remain unclear.
  • Existing research presents conflicting evidence regarding cellular and molecular pathways involved in beta cell destruction.
  • Mechanisms by which autoreactive immune cells evade surveillance are poorly understood.

Purpose of the Study:

  • To review the complex interplay of cellular and molecular mechanisms in beta cell apoptosis during autoimmune diabetes.
  • To elucidate the roles of various apoptotic pathways, including perforin/granzyme and Fas/Fas-ligand (FasL), in insulitis.
  • To explore how inflammation perpetuates a cycle of beta cell death in diabetes pathogenesis.

Main Methods:

  • Literature review synthesizing experimental evidence on beta cell apoptosis.

Related Experiment Videos

  • Analysis of multiple apoptotic pathways (perforin/granzyme, Fas/FasL) in autoimmune diabetes.
  • Examination of immune cell subsets (CD8(+) and CD4(+) T cells) and cytokine involvement.

    • Main Results:

    • Multiple redundant apoptotic pathways, including perforin/granzyme and Fas/FasL, contribute to beta cell injury.
    • CD8(+) T cells may preferentially use perforin/granzyme, while CD4(+) T cells may favor FasL in insulitis.
    • Cytokines induce Fas expression on beta cells, sensitizing them to FasL-mediated apoptosis.

    Conclusions:

    • A combination of cellular and molecular mechanisms drives beta cell death in autoimmune diabetes.
    • Redundant apoptotic pathways highlight the complexity of beta cell destruction.
    • Inflammation creates a self-perpetuating cycle of beta cell death, contributing to irreversible diabetes pathogenesis.